These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33312849)

  • 1. Acute exacerbation of idiopathic pulmonary fibrosis: who to treat, how to treat.
    Kulkarni T; Duncan SR
    Curr Pulmonol Rep; 2019 Dec; 8(4):123-130. PubMed ID: 33312849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies.
    Biondini D; Balestro E; Sverzellati N; Cocconcelli E; Bernardinello N; Ryerson CJ; Spagnolo P
    Expert Rev Respir Med; 2020 Apr; 14(4):405-414. PubMed ID: 31994940
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi Technique.
    Maher TM; Whyte MK; Hoyles RK; Parfrey H; Ochiai Y; Mathieson N; Turnbull A; Williamson N; Bennett BM
    Adv Ther; 2015 Oct; 32(10):929-43. PubMed ID: 26498943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
    Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
    BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time for Prevention of Idiopathic Pulmonary Fibrosis Exacerbation.
    Richeldi L
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S181-5. PubMed ID: 26595737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute exacerbation of idiopathic pulmonary fibrosis triggered by
    Suzuki A; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Mori Y; Kondoh Y
    Respir Med Case Rep; 2018; 23():103-106. PubMed ID: 29719792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
    Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
    Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute exacerbation of idiopathic pulmonary fibrosis a narrative review primary focus on treatments.
    Luo X; Xiang F
    J Thorac Dis; 2024 Jul; 16(7):4727-4741. PubMed ID: 39144320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute exacerbations of interstitial lung disease: lessons from idiopathic pulmonary fibrosis.
    Spagnolo P; Wuyts W
    Curr Opin Pulm Med; 2017 Sep; 23(5):411-417. PubMed ID: 28582317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis.
    Kulkarni T; Criner GJ; Kass DJ; Rosas IO; Scholand MB; Dilling DF; Summer R; Duncan SR
    BMC Pulm Med; 2024 Mar; 24(1):143. PubMed ID: 38509495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.
    Tsushima K; Yamaguchi K; Kono Y; Yokoyama T; Kubo K; Matsumura T; Ichimura Y; Abe M; Terada J; Tatsumi K
    Pulm Pharmacol Ther; 2014 Dec; 29(2):233-40. PubMed ID: 24836398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies.
    Juarez MM; Chan AL; Norris AG; Morrissey BM; Albertson TE
    J Thorac Dis; 2015 Mar; 7(3):499-519. PubMed ID: 25922733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute exacerbation of idiopathic pulmonary fibrosis induced by pertussis: the first case report.
    Hirai K; Homma T; Yamaguchi F; Yamaguchi M; Suzuki S; Tanaka A; Ohnishi T; Sagara H
    BMC Pulm Med; 2019 Jan; 19(1):15. PubMed ID: 30642317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?
    Marchioni A; Tonelli R; Ball L; Fantini R; Castaniere I; Cerri S; Luppi F; Malerba M; Pelosi P; Clini E
    Crit Care; 2018 Mar; 22(1):80. PubMed ID: 29566734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute exacerbations complicating interstitial lung disease.
    Ryerson CJ; Collard HR
    Curr Opin Pulm Med; 2014 Sep; 20(5):436-41. PubMed ID: 25032813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Isshiki T; Sakamoto S; Homma S
    Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31137593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Kishaba T
    Eurasian J Med; 2017 Oct; 49(3):204-206. PubMed ID: 29123445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome.
    Okuda R; Hagiwara E; Katano T; Ikeda S; Sekine A; Kitamura H; Baba T; Okudela K; Ohashi K; Ogura T
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):39-46. PubMed ID: 32476935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.
    Ryerson CJ; Cottin V; Brown KK; Collard HR
    Eur Respir J; 2015 Aug; 46(2):512-20. PubMed ID: 26232481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
    Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
    Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.